C12Y 601/01012
Aspartate-trna ligase
Official title: Aspartate-tRNA ligase (6.1.1.12)
C12Y601/01012 (Aspartate-trna ligase) appears on 8 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 9
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 20 Feb 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities20 Feb 2018US 9,896,680 B2aTyr Pharma, Inc.
- PEGylated aspartyl-tRNA synthetase polypeptides21 Nov 2017US 9,822,353 B2aTyr Pharma, Inc.
- Aspartyl-tRNA synthetase-Fc conjugates27 Jun 2017US 9,688,978 B2aTyr Pharma, Inc.
- Polypeptide structural motifs associated with cell signaling activity27 Sep 2016US 9,453,214 B2aTyr Pharma, Inc.
- OB fold domains10 Nov 2015US 9,181,543 B2OBodies Limited
- Method of treating lbsl by enhancing dars2 expression16 Apr 2026US 2026/0103728 A1Kennedy Krieger Institute, Inc.
- Polypeptide structural motifs associated with cell signaling activity6 Apr 2017US 2017/0096494 A1aTyr Pharma, Inc.
- Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities11 Aug 2016US 2016/0230163 A1aTyr Pharma, Inc.
- Pegylated aspartyl-trna synthetase polypeptides11 Jun 2015US 2015/0159148 A1aTyr Pharma, Inc.
- Polypeptide structural motifs associated with cell signaling activity5 Mar 2015US 2015/0064188 A1aTyr Pharma, Inc.
Most cited
By later US patents
- Aspartyl-tRNA synthetase-Fc conjugates25US 9,688,978 B2aTyr Pharma, Inc. · 2017
- aspS9US 6,265,188 B1SmithKline Beecham Corporation · 2001
- Polypeptide structural motifs associated with cell signaling activity3US 9,453,214 B2aTyr Pharma, Inc. · 2016
- PEGylated aspartyl-tRNA synthetase polypeptides2US 9,822,353 B2aTyr Pharma, Inc. · 2017
- Asps1US 5,882,892 ASmithKline Beecham Corporation · 1999